OVARIAN CANCER

Austria adopted interferon combination of chemotherapy and women's ovarian cancer treatment, and achieved better than chemotherapy alone effect.

Austrian University of Innsbruck gynecological experts led by Professor Christian Anmaerte a Gynecologic Oncology Group study started three years ago one of the study. Their 148 already one ovarian cancer surgery in women with a combination of chemotherapy for the treatment of interferon test. Six patients received treatment three times a week in treatment, and the other a comparison group of patients is only chemotherapy. Results of 51% in patients treated with interferon did not recur tumor, and comparison group only 38% of patients with tumors did not recur.

Tags: blood, body, cancer, cell, cells, chemotherapy, eat, ert, group, growth, gynecological, interferon, ovarian, patients, protein, study, surgery, therapy, time, treatment, tumor, tumors, women

Common and prognosis factors:

• clinical stage and is closely related to survival;

• histological type and grade pathology and prognosis is directly related;

• differentiation and biological characteristics and the prognosis also directly related to a direct impact on the survival rate and survival time.

• In addition, the age factor and the prognosis of more closely. Another treatment option with a reasonable and thorough, but also directly affect the prognosis of ovarian cancer.

Tags: age, body, cancer, chemotherapy, clinical, eat, exploration, life, method, ovarian, patients, prognosis, rate, residual, surgery, survival, therapy, time, treatment, tumor

Kikuchi, the Japanese report, have received platinum multidrug chemotherapy for recurrent ovarian cancer Japanese women, a weekly carboplatin and paclitaxel chemotherapy in a meeting, can significantly prolong survival, and patients can be tolerated. (Int J Cancer YORK 2005,15:45)

The case control study included surgery and platinum-based adjuvant chemotherapy complete remission for at least 6 months after the recurrence of ovarian cancer patients. Of the 68 patients, 27 patients received a weekly meeting of Taxol and carboplatin chemotherapy (WTJ) (Group I), carboplatin (AUC area under the curve for 2) plus paclitaxel (80 mg/m2); The remaining 41 patients (Group II) to platinum-based (P ) other chemotherapy, 37 patients with CAP program, a monthly meeting of carboplatin and paclitaxel program four cases.

Tags: cancer, carboplatin, cases, chemotherapy, clinical, drug, drugs, eat, family, gene, group, growth, increased, intraperitoneal, method, ovarian, ovary, p53, paclitaxel, patients, preventive, prognosis, protein, rate, risk, screening, second, study, surgery, survival, syndrome, taxol, therapy, time, treatment, women

Wagner, the German pair of recurrence of ovarian cancer a mouse monoclonal anti-idiotypic antibody immune ACA125 consolidation therapy (tumor-associated antigen CA125 simulation) research. The results confirmed that the treatment of patients with prolonged survival.

Tags: age, anti, body, cancer, cases, cisplatin, clinical, eat, group, injection, method, ovarian, patients, response, study, survival, therapy, time, treatment, tumor

A benign ovarian tumors young patients affected Annex tumor resection or stripped of. If both bilateral ovarian tumors, should fight to retain part of normal ovarian tissue. Before post-clearance as abdominal specimens suspected malignant sent frozen biopsy. Patients before and after menopause to be hysterectomy and bilateral resection of the Annex to activities.

2, malignant ovarian tumor treatment to the main, supplemented by chemotherapy, and radiotherapy.

(1) to general surgery for hysterectomy, bilateral Annex and the omentum resection. Patients with advanced cancer should be possible for the transfer to that reduction of tumor cells. As for retroperitoneal lymph node removal of the therapeutic value can not be determined.

Tags: abdominal, age, annex, anti, benign, cancer, cell, cells, chemotherapy, cisplatin, days, dose, drug, drugs, eat, ert, exploration, gene, grams, infusion, injection, intraperitoneal, intravenous, irradiation, lymph, malignant, node, ovarian, patients, protein, radiation, radiotherapy, rate, reduce, resection, residual, surgery, surgical, survival, therapy, time, toxicity, treatment, tumor, tumors, usually

Abstract: The FDA approved a new treatment of advanced ovarian cancer on the first line of the short-term treatment programs, in the treatment of cisplatin infusion again, Bristol-Myers Squibb pharmaceutical factories paclitaxel (Taxol) 3 hours.

The United States Food and Drug Administration (FDA) approved a new treatment of advanced ovarian cancer on the first line of the short-term treatment programs, in the treatment of cisplatin injection again, Bristol-Myers Squibb pharmaceutical factories paclitaxel (Taxol) 3 hours.

Tags: administration, age, anti, blood, breast, cancer, cell, cells, cisplatin, clinical, drug, drugs, eat, fat, grams, head, infusion, injection, neck, ovarian, paclitaxel, patients, radiotherapy, reduce, risk, study, taxol, therapy, toxicity, treatment, women

Tumor resistance of the tumor cells to anticancer drugs that showed no reaction of the state of ovarian cancer chemotherapy failure is the central link.

In the cell level can be divided into the inherent resistance of resistance and acquired resistance of the two. Acquired resistance of ovarian cancer is the main reason for resistance. Resistance of ovarian cancer treatment at the following categories of major new strategy.

; To detoxification pathway-based chemotherapy

1. Resistance

Tags: age, anti, blood, body, cancer, cases, cell, cells, chemotherapy, clinical, dose, drug, drugs, eat, group, groups, growth, method, ovarian, paclitaxel, patients, poor, prognosis, protein, rate, reduce, response, risk, second, tea, therapy, time, toxicity, treatment, tumor, tumors

Ovarian cancer mortality of the first Habitat gynecologic malignancies, is a thorough treatment of cytoreductive surgery, postoperative chemotherapy supplemented by polymerization. Chemotherapy patients in stage physical function, quality of life decreased markedly different degrees of psychological pressure. The tense psychological, can directly affect the treatment outcome is not conducive to the smooth progress of chemotherapy. Chemotherapy is the use of chemical substances at the molecular level and to correct various carcinogenic factor in blocking the abnormal proliferation of normal cells of genetic variation is promising in the treatment of cancer, attention to a very popular method of treatment. Right gynecologic malignancies, has been widely used in clinical chemotherapy and received very good results. But the chemotherapy drugs in inhibiting tumor cell growth, but also affect normal cell metabolism, toxicity caused a reaction. Now I Section 2003 to November 1 of 72 cases of ovarian cancer patients undergoing chemotherapy psychological observation, the main problems are psychological.

Tags: age, anti, body, cancer, care, cases, cause, cell, cells, chemotherapy, clinical, confidence, drug, drugs, eat, family, fat, gene, growth, life, method, ovarian, pain, patients, physical, positive, psychological, quality, rate, reduce, response, surgery, symptoms, therapy, time, toxicity, treatment, tumor

1. The only benign ovarian tumor treatment is surgical excision. Cyst less than 5 ~ 6 cm in diameter, observed 3 to 6 months, continue to increase, or tumor is smaller than 5 cm in diameter, but for solid tumors, surgical resection should be.

2. Children, pregnant young patients with no more side to side or ovariectomy Annex resection. As for the bilateral benign ovarian tumors, ovarian tumors to be stripped of, as far as possible to retain some ovarian tissue to maintain menstruation and reproductive functions. Right after menopause, and bilateral ovarian tumors while uterine bilateral resection of the annex, was advocated in recent years should be retained normal ovarian tissue, and maintain normal physiological functions of women.

Tags: annex, benign, cancer, children, cyst, eat, exploration, ovarian, patients, resection, surgical, treatment, tumor, tumors, uterine, women

Ovarian cancer is one of the female genital common tumor, the treatment of surgical resection mainly, but because of the lack of effective early ovarian cancer diagnostic methods, to the late effects of surgery are often poor, I begin by 1994, 41 cases of ovarian cancer patients percutaneous internal iliac aneurysms of the chemotherapy, and has achieved recent good results.

An information and methods <BR> <BR> 1.1 general information 41 patients, 12 cases of pregnancy, aged 25 to 56 years old, are bloating, abdominal pain, ascites and other symptoms, the CT or ultrasound for ovarian cancer are diagnosed and into intervention Branch.

Tags: abdominal, administration, age, anti, bleeding, blood, cancer, cases, cause, chemotherapy, cisplatin, drug, drugs, early, eat, examination, fat, gene, injection, intraperitoneal, intravenous, mass, method, oppression, ovarian, pain, patients, poor, resection, response, skin, surgery, surgical, symptoms, therapy, time, toxicity, treatment, tumor, tumors